A recent study demonstrated the efficacy of Cedrol in inhibiting HT29 CRC cell growth by destabilising lipid rafts through the redistribution of cholesterol from the plasma membrane, blocking Akt/mTOR signalling and inducing mitochondrial intrinsic apoptosis, thereby resisting cell death [171]. Here, AKT1 is linked to colorectal carcinoma.